MPM BioImpact LLC Diversified Active

CIK: 0001687078 · Show all filings

Period: Q4 2023 (← Previous) (Next →)

Filing Date: Feb 13, 2024

Total Value ($000): $427,429 (100.0% shares, 0.0% debt)

Holdings (32)

CGEM Cullinan Oncology, Inc. 18.2%

Value ($000) $77,936 Shares 7,648,268 Est. Cost $40.60 Unrealized -78.2%

IOVA Iovance Biotherapeutics Inc 6.3%

Value ($000) $26,743 Shares 3,289,470 Est. Cost $9.98 Unrealized -47.6%

OLMA Olema Pharmaceuticals, Inc. 6.1%

Value ($000) $26,056 Shares 1,857,136 Est. Cost $9.16 Unrealized +46.7%

GERN Geron Corporation 5.3%

Value ($000) $22,610 Shares 10,715,620 Est. Cost $1.65 Unrealized +18.0%

— iTeos Therapeutics, Inc. 4.5%

Value ($000) $19,118 Shares 1,745,943 Est. Cost $24.67 Unrealized —

ALXO ALX Oncology Holdings Inc. 4.4%

Value ($000) $18,832 Shares 1,264,759 Est. Cost $9.49 Unrealized 0.0%

MLTX Moonlake Immunotherapeutics 4.2%

Value ($000) $17,789 Shares 294,576 Est. Cost $26.91 Unrealized +91.5%

CRNX Crinetics Pharmaceuticals Inc. 4.0%

Value ($000) $17,016 Shares 478,234 Est. Cost $21.22 Unrealized +44.5%

— Karuna Therapeutics Inc 3.9%

Value ($000) $16,863 Shares 53,279 Est. Cost $216.85 Unrealized —

INSM Insmed Incorporated 3.8%

Value ($000) $16,367 Shares 528,150 Est. Cost $19.24 Unrealized +34.8%

— CYMABAY THERAPEUTICS INC 3.4%

Value ($000) $14,436 Shares 611,181 Est. Cost $14.91 Unrealized —

— Repare Therapeutics, Inc. 2.8%

Value ($000) $11,971 Shares 1,639,849 Est. Cost $31.02 Unrealized —

NTLA Intellia Therapeutics, Inc. 2.7%

Value ($000) $11,665 Shares 382,598 Est. Cost $77.45 Unrealized -62.9%

FOLD Amicus Therapeutics Inc. 2.4%

Value ($000) $10,158 Shares 715,883 Est. Cost $11.28 Unrealized +0.7%

RGNX REGENXBIO Inc. 2.3%

Value ($000) $9,856 Shares 549,078 Est. Cost $29.05 Unrealized -39.4%

MDGL Madrigal Pharmaceuticals inc 2.2%

Value ($000) $9,466 Shares 40,910 Est. Cost $136.15 Unrealized +28.5%

GPCR Structure Therapeutics Inc. 2.2%

Value ($000) $9,403 Shares 230,696 Est. Cost $50.42 Unrealized —

— Avadel Pharmaceuticals PLC 2.2%

Value ($000) $9,390 Shares 664,986 Est. Cost $13.88 Unrealized —

— MORPHIC HOLDING INC 2.2%

Value ($000) $9,350 Shares 323,742 Est. Cost $25.19 Unrealized —

HOWL Werewolf Therapeutics, Inc. 2.2%

Value ($000) $9,218 Shares 2,388,011 Est. Cost $13.70 Unrealized -81.4%

RLAY Relay Therapeutics Inc. 2.1%

Value ($000) $9,161 Shares 832,017 Est. Cost $17.41 Unrealized -51.5%

XERS Xeris Biopharma Holdings Inc 2.1%

Value ($000) $9,041 Shares 3,847,232 Est. Cost $2.55 Unrealized -27.5%

— Verve Therapeutics, Inc 2.1%

Value ($000) $8,896 Shares 638,163 Est. Cost $30.36 Unrealized —

RVMD Revolution Medicines, Inc. 1.8%

Value ($000) $7,841 Shares 273,408 Est. Cost $26.97 Unrealized -10.9%

AXSM Axsome Therapeutics, Inc. 1.7%

Value ($000) $7,433 Shares 93,387 Est. Cost $64.41 Unrealized +3.8%

VKTX VIKING THERAPEUTICS INC 1.4%

Value ($000) $6,054 Shares 325,284 Est. Cost $14.30 Unrealized -8.6%

ADAPY Adaptimmune Therapeutics plc 0.9%

Value ($000) $4,041 Shares 5,095,912 Est. Cost $0.93 Unrealized —

— Harpoon Therapeutics, Inc. 0.9%

Value ($000) $3,635 Shares 319,670 Est. Cost $4.03 Unrealized —

IRON Disc Medicine Inc 0.7%

Value ($000) $2,888 Shares 50,000 Est. Cost $51.20 Unrealized 0.0%

VRDN Viridian Therapeutics Inc 0.5%

Value ($000) $2,178 Shares 100,000 Est. Cost $25.65 Unrealized -38.5%

— Inozyme Pharma Inc. 0.3%

Value ($000) $1,379 Shares 323,813 Est. Cost $7.14 Unrealized —

PHAT Phathom Pharmaceuticals inc 0.1%

Value ($000) $639 Shares 70,000 Est. Cost $14.37 Unrealized -40.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CGEM	Cullinan Oncology, Inc.	7,648,268	$77,936	18.2%	$40.60	-78.2%	Common	230031106
IOVA	Iovance Biotherapeutics Inc	3,289,470	$26,743	6.3%	$9.98	-47.6%	Common	462260100
OLMA	Olema Pharmaceuticals, Inc.	1,857,136	$26,056	6.1%	$9.16	+46.7%	Common	68062P106
GERN	Geron Corporation	10,715,620	$22,610	5.3%	$1.65	+18.0%	Common	374163103
—	iTeos Therapeutics, Inc.	1,745,943	$19,118	4.5%	$24.67	—	Common	46565G104
ALXO	ALX Oncology Holdings Inc.	1,264,759	$18,832	4.4%	$9.49	0.0%	Common	00166B105
MLTX	Moonlake Immunotherapeutics	294,576	$17,789	4.2%	$26.91	+91.5%	Class A Ord.	61559X104
CRNX	Crinetics Pharmaceuticals Inc.	478,234	$17,016	4.0%	$21.22	+44.5%	Common	22663K107
—	Karuna Therapeutics Inc	53,279	$16,863	3.9%	$216.85	—	Common	48576A100
INSM	Insmed Incorporated	528,150	$16,367	3.8%	$19.24	+34.8%	Common	457669307
—	CYMABAY THERAPEUTICS INC	611,181	$14,436	3.4%	$14.91	—	Common	23257D103
—	Repare Therapeutics, Inc.	1,639,849	$11,971	2.8%	$31.02	—	Common	760273102
NTLA	Intellia Therapeutics, Inc.	382,598	$11,665	2.7%	$77.45	-62.9%	Common	45826J105
FOLD	Amicus Therapeutics Inc.	715,883	$10,158	2.4%	$11.28	+0.7%	Common	03152W109
RGNX	REGENXBIO Inc.	549,078	$9,856	2.3%	$29.05	-39.4%	Common	75901B107
MDGL	Madrigal Pharmaceuticals inc	40,910	$9,466	2.2%	$136.15	+28.5%	Common	558868105
GPCR	Structure Therapeutics Inc.	230,696	$9,403	2.2%	$50.42	—	Sponsored ADS	86366E106
—	Avadel Pharmaceuticals PLC	664,986	$9,390	2.2%	$13.88	—	Sponsored ADR	05337M104
—	MORPHIC HOLDING INC	323,742	$9,350	2.2%	$25.19	—	Common	61775R105
HOWL	Werewolf Therapeutics, Inc.	2,388,011	$9,218	2.2%	$13.70	-81.4%	Common	95075A107
RLAY	Relay Therapeutics Inc.	832,017	$9,161	2.1%	$17.41	-51.5%	Common	75943R102
XERS	Xeris Biopharma Holdings Inc	3,847,232	$9,041	2.1%	$2.55	-27.5%	Common	98422E103
—	Verve Therapeutics, Inc	638,163	$8,896	2.1%	$30.36	—	Common	92539P101
RVMD	Revolution Medicines, Inc.	273,408	$7,841	1.8%	$26.97	-10.9%	Common	76155X100
AXSM	Axsome Therapeutics, Inc.	93,387	$7,433	1.7%	$64.41	+3.8%	Common	05464T104
VKTX	VIKING THERAPEUTICS INC	325,284	$6,054	1.4%	$14.30	-8.6%	Common	92686J106
ADAPY	Adaptimmune Therapeutics plc	5,095,912	$4,041	0.9%	$0.93	—	Sponsored ADR	00653A107
—	Harpoon Therapeutics, Inc.	319,670	$3,635	0.9%	$4.03	—	Common	41358P205
IRON	Disc Medicine Inc	50,000	$2,888	0.7%	$51.20	0.0%	Common	254604101
VRDN	Viridian Therapeutics Inc	100,000	$2,178	0.5%	$25.65	-38.5%	Common	92790C104
—	Inozyme Pharma Inc.	323,813	$1,379	0.3%	$7.14	—	Common	45790W108
PHAT	Phathom Pharmaceuticals inc	70,000	$639	0.1%	$14.37	-40.0%	Common	71722W107